Clinical Trial Update: Phase I Trial of Combination of FOLFIRI and SOM 230 [Phase 1]

View source ↗

Summary

A Phase I trial evaluating the combination of FOLFIRI and SOM 230 for digestive system neoplasms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Digestive System Neoplasms

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Irinotecan (Camptosar) (Irinotecan)
• Leucovorin (folinic acid)
• Pasireotide (SOM230) (pasireotide)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Gastrointestinal Tumor | Phase 1 | Status: COMPLETED